Cantor Fitzgerald analyst Sarah James lowered the firm’s price target on Acadia Healthcare (ACHC) to $22 from $25 and keeps a Neutral rating on the shares. Cantor remains on the sidelines as volumes and rate headwinds continue to pressure the recovery timeline with no clear catalyst for reversal, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare price target lowered to $28 from $31 at UBS
- Acadia Healthcare Reports Q3 Revenue Growth Amid Challenges
- Acadia Healthcare sentiment likely to worsen further, says Cantor Fitzgerald
- Acadia Healthcare COO Nasser Khan resigns
- Acadia Healthcare lowers FY25 adjusted EPS $2.35-$2.45 from $2.45-$2.65